| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 1997 | Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs | Cheng, T. L.; Chen, B. M.; Chan, L. Y.; Wu, P. Y.; Chern, J. W.; Roffler, S. R. | Cancer Immunol Immunother 44, 305-315 | |||
| 2000 | Proactive antitumor compounds | Roffler, S. R.; Chern, J. W.; Leu, Y. L. | US Patent #6,043,367 | |||
| 2003 | Proactive antitumor compounds | Roffler, S. R.; Chern, J. W.; Leu, Y. L. | European Patent EP0990661 | |||
| 1992 | Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy | Wang, S. M.; Chern, J. W.; Yeh, M. Y.; Ng, J. C.; Tung, E.; Roffler, S. R. | Cancer Res 52, 4484-4491 | |||
| 1993 | Studies on 1,2,4-Benzothiadiazine 1,1-dioxides VII and Quinazolinones IV: Synthesis of Novel Built-in Hydroxyguanine Tricycles as Potential Anticancer Agents | Chern, J. W.; Liaw, Y. C. ; Chen, C. S.; Rong, J. G.; Huang, C. L.; Chan, C. H.; Wang, A. H. J. | Heterocycles 36, 1091-1103 | |||
| 1997 | Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents | Chern, J. W.; Leu, Y. L.; Wang, S. S.; Jou, R.; Lee, C. F.; Tsou, P. C.; Hsu, S. C.; Liaw, Y. C. ; Lin, H. M. | J Med Chem 40, 2276-2286 | |||
| 1992 | Unusual conformational flexibility in N1-substituted uncommon purine nucleosides. Crystal structure of 1-allyl-isoguanosine and 1-allyl-xanthosine | Liaw, Y. C. ; Chern, J. W.; Lin, G. S.; Wang, A. H. J. | FEBS Lett 297, 4-8 |
